AZNCX
Price
$9.99
Change
+$0.03 (+0.30%)
Updated
Dec 3 closing price
Net Assets
4.77B
RLBGX
Price
$39.90
Change
+$0.11 (+0.28%)
Updated
Dec 3 closing price
Net Assets
269.37B
Interact to see
Advertisement

AZNCX vs RLBGX

Header iconAZNCX vs RLBGX Comparison
Open Charts AZNCX vs RLBGXBanner chart's image
Virtus Income & Growth C
Price$9.99
Change+$0.03 (+0.30%)
VolumeN/A
Net Assets4.77B
American Funds American Balanced R6
Price$39.90
Change+$0.11 (+0.28%)
VolumeN/A
Net Assets269.37B
AZNCX vs RLBGX Comparison Chart in %
View a ticker or compare two or three
VS
AZNCX vs. RLBGX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNCX is a Buy and RLBGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 269B vs. AZNCX (4.77B). RLBGX (1.98) and AZNCX (1.91) have matching dividends . AZNCX was incepted earlier than RLBGX: AZNCX (19 years) vs RLBGX (17 years). AZNCX (1.90) is less costly to investors than RLBGX (0.25). AZNCX is a more actively managed with annual turnover of: 76.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than AZNCX: RLBGX (250) vs AZNCX (2500). RLBGX annual gain was more profitable for investors over the last year : 9.66 vs. AZNCX (2.36). RLBGX return over 5 years is better than : 41.12 vs. AZNCX (-4.36).
AZNCXRLBGXAZNCX / RLBGX
Total Expense Ratio1.900.25760%
Annual Report Gross Expense Ratio1.900.25760%
Fund Existence19 years17 years-
Gain YTD4.62316.95327%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.77B269B2%
Annual Yield % from dividends1.911.9897%
Returns for 1 year2.369.6624%
Returns for 3 years14.0241.5834%
Returns for 5 years-4.3641.12-11%
Returns for 10 years10.3278.2413%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETHSX14.15N/A
N/A
Eaton Vance Worldwide Health Sci A
OTCGX22.13N/A
N/A
MFS Mid Cap Growth R1
CVERX15.92N/A
N/A
Columbia Select Mid Cap Value Instl 2
HRLTX9.82N/A
N/A
Hartford Real Asset R5
PGIRX26.26N/A
N/A
Polen Global Growth Investor